Clarissa Mathias, Yasushi Goto, Carolin Gross-Ophoff-Mueller, Shun Lu, Delvys Rodriguez-Abreu, Alona Zer, Moritz Wolfgang Drachsler, Maozhen Gong, James Hurlock, Jakub Tyszecki, Byoung Chul Cho. "ARTEMIDE-Lung03: A phase 3, randomized, double-blind, multicenter, global study of rilvegostomig or pembrolizumab in combination with platinum-based chemotherapy as first-line treatment for patients with metastatic non-squamous non-small-cell lung cancer whose tumors express PD-L1.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps8653